ZNTL earnings: a positive outcome, +6.7%

+6.7%Zentalis Pharmaceuticals, Inc. (ZNTL) →

On February 24, 2022, Zentalis Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.7% in the window around the event. It had already run -16.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$47.69

1d before

$50.90

Event day

$51.32

1d after

$50.41

5d after

Pre-catalyst setup

-16.1%

30-day run-up

7321%

30-day volatility

1.1×

volume spike

ZNTL catalyst calendar More earningss Prediction track record Full catalyst calendar